I recruit biotech executive and clinical/regulatory leadership in San Diego — the third-largest U.S. life sciences cluster, anchored around Torrey Pines and UTC/Sorrento Mesa — through a market recovering from 2025 layoffs at Illumina and Pfizer toward early core R&D hiring growth. Contingent-first, no up-front retainer, twelve-month guarantee.
Biotech Recruiters in San Diego
San Diego is consistently ranked the third-largest life sciences cluster in the U.S., anchored around Torrey Pines — home to UC San Diego, Scripps Research, the Salk Institute, and Sanford Burnham Prebys — and the University Towne Centre/Sorrento Mesa corridor, with well over 1,300 life science companies in the region. The sector employed 71,448 workers in 2024 and contributed $54.1 billion to the local economy, even as direct biotechnology-subsector employment declined roughly 6% to 10% year-over-year as of Q3 2025.
The market’s recent layoffs are distinct to its genomics- and diagnostics-heavy employer base: Illumina cut 172 jobs in April 2025, following 96 cuts two months earlier; Pfizer sold its Torrey Pines campus for $255 million while cutting 56 jobs; Pacira BioSciences cut 71 jobs; and BioAtla and Gossamer Bio each cut a majority of staff amid strategic reviews. Despite that, San Diego shows real signs of a hiring inflection — CBRE reported the highest year-over-year job growth in nearly three years in core biotechnology R&D and pharmaceutical manufacturing specifically, even as total life sciences employment stayed down about 4% year-over-year, a “flight to core” pattern rather than a broad rebound. A local “talent readiness crisis” compounds it: even with job postings down 20% locally, roughly 77% to 80% of San Diego life sciences employers report struggling to fill critical research, manufacturing, and regulatory affairs roles.
Where this fits in San Diego
Core R&D and pharmaceutical manufacturing leadership searches, the specific subsector where CBRE identified the strongest recent job growth — the segment where “flight to core” hiring is concentrated.
Executive searches at platforms navigating genomics and diagnostics-specific disruption, where a CEO or CSO candidate needs real context on the wave of restructuring at comparable San Diego companies.
VP of Regulatory Affairs and VP of Clinical Development searches, where the skills/specialization mismatch behind San Diego’s talent-readiness crisis means broad life-sciences experience isn’t enough — sourcing has to target candidates with direct research, manufacturing, or regulatory-affairs depth.
How I run a San Diego search
Every search starts with where the platform sits relative to San Diego’s uneven recovery — a core R&D or manufacturing mandate carries different urgency than a role at a company still working through a strategic review. Outreach then targets candidates with real pathway- and pipeline-relevant experience, informed by the concentration of comparable Torrey Pines and Sorrento Mesa platforms. Every placement carries the standard twelve-month guarantee.
Hub home: Biotech Recruiters. Cross-vertical: executive search agency.
Schedule a 30-Minute Call with Dan — Calendly, dpoore@bluesignal.com, or 669-900-4504. That is the only conversion path.
Frequently asked questions
How does San Diego rank among U.S. biotech clusters?
San Diego is consistently ranked the third-largest life sciences cluster in the U.S., anchored around Torrey Pines (UC San Diego, Scripps Research, the Salk Institute, Sanford Burnham Prebys) and University Towne Centre/Sorrento Mesa, with well over 1,300 life science companies in the region.
What layoffs has San Diego biotech seen recently?
Illumina cut 172 jobs in April 2025 following 96 cuts two months earlier, Pfizer sold its Torrey Pines campus for $255 million while cutting 56 jobs, Pacira BioSciences cut 71 jobs, and BioAtla and Gossamer Bio each cut a majority of staff amid strategic reviews.
Is the San Diego biotech market recovering?
There are early signs of an inflection — CBRE reported the highest year-over-year job growth in nearly three years in core biotechnology R&D and pharmaceutical manufacturing subsectors, even as total life sciences employment stayed down about 4% year-over-year, suggesting a "flight to core" rather than a broad rebound.
What's the engagement model for a San Diego biotech search?
Contingent-first, no up-front retainer, twelve-month replacement guarantee — the same terms as every other search this desk runs nationally.